In the field of drug development, successful translation from bench to bedside is crucial for bringing new and innovative treatments to patients in need. However, many promising drug and vaccine candidates face pitfalls and show-stoppers that prevent them from reaching clinical application. By addressing potential issues early in the planning process and utilizing a Target Product Profile (TPP) as a roadmap, developers can navigate the regulatory landscape more effectively and increase the chances of success. This reverse planning technique, starting with the end goal in mind, can help to identify and mitigate risks throughout the development process, ultimately improving the accessibility of life-saving medications for patients
worldwide.
From Innovation to Medication – Planning for Patients‘ Access to Life- saving Medication Right from the Beginning of Drug Development
